
National Research Corporation NRC
€ 16.37
0.13%
Quartalsbericht 2026-Q1
hinzugefügt 06.05.2026
National Research Corporation DPO 2011-2026 | NRC
DPO Jährlich National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 10.1 | 4.7 | 4.41 | 6.13 | 5.02 | 7.26 | 6.15 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 10.1 | 4.41 | 6.25 |
DPO anderer Aktien in der Diagnostik & Forschung
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
50.1 | $ 115.35 | 0.25 % | $ 35.1 B | ||
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
4.24 K | $ 6.9 | -24.26 % | $ 9.18 M | ||
|
Castle Biosciences
CSTL
|
65.8 | $ 21.05 | 6.91 % | $ 610 M | ||
|
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
196 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
35.2 | $ 17.55 | -0.68 % | $ 540 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 21.6 | 0.28 % | $ 1.15 B | ||
|
Guardant Health
GH
|
48.6 | $ 125.53 | 4.74 % | $ 15.7 B | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
33 | $ 1.8 | - | $ 7.96 M | ||
|
ICON Public Limited Company
ICLR
|
9.51 | $ 116.97 | 2.74 % | $ 9.65 B | ||
|
Illumina
ILMN
|
56.3 | $ 148.65 | 2.36 % | $ 23.6 B | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Lantheus Holdings
LNTH
|
23.6 | $ 99.78 | -0.28 % | $ 6.73 B | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
Mettler-Toledo International
MTD
|
53.4 | $ 1 091.39 | -0.9 % | $ 22.5 B | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 162.28 | 3.66 % | $ 8.04 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
NeoGenomics
NEO
|
19.7 | $ 9.4 | 1.4 % | $ 1.2 B | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
13.3 | $ 430.56 | 0.34 % | $ 12.4 B | ||
|
Natera
NTRA
|
17.9 | $ 201.65 | 0.37 % | $ 19.8 B | ||
|
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
45.9 | $ 3.89 | 0.91 % | $ 360 M | ||
|
Personalis
PSNL
|
65.7 | $ 9.19 | 2.74 % | $ 820 M | ||
|
Senseonics Holdings
SENS
|
68 | $ 6.3 | -2.05 % | $ 263 M | ||
|
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
1.44 K | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
32.4 | $ 2.38 | -3.64 % | $ 5.47 M | ||
|
Twist Bioscience Corporation
TWST
|
12.5 | $ 65.39 | 0.8 % | $ 3.91 B | ||
|
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 258.13 | -0.11 % | $ 21.5 B | ||
|
Thermo Fisher Scientific
TMO
|
49.3 | $ 448.76 | 0.11 % | $ 169 B | ||
|
Waters Corporation
WAT
|
102 | $ 340.42 | 0.51 % | $ 20.3 B | ||
|
Trinity Biotech plc
TRIB
|
163 | $ 0.67 | 2.95 % | $ 241 M | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 9.25 | 1.2 % | $ 2.01 B | ||
|
Quest Diagnostics Incorporated
DGX
|
14.7 | $ 193.95 | 0.54 % | $ 21.5 B |